Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Amniotic Membrane Market Size
The global amniotic membrane market size was valued at around USD 1.7 billion in 2023 and is estimated to grow at a 7.9% CAGR from 2024 to 2032. The amniotic membrane is a thin, flexible tissue that lines the amniotic sac during pregnancy. It surrounds and protects the developing fetus while providing essential nutrients and growth factors. After childbirth, it can be used in medical treatments and surgeries for its regenerative properties and ability to promote healing.
To get key market trends
Growing demand for regenerative medicine is anticipated to drive market growth. Regenerative medicine aims to restore or replace damaged tissues and organs using techniques such as stem cell therapy, tissue engineering, and biomaterials. Amniotic membranes are increasingly recognized for their potential in these applications due to their unique properties. A 2023 study published by the National Library of Medicine highlighted the presence of key bioactive molecules in the amniotic membrane, underscoring their regenerative properties.
Amniotic Membrane Market Report Attributes
Report Attribute
Details
Base Year:
2023
Amniotic Membrane Market Size in 2023:
USD 1.7 Billion
Forecast Period:
2024 - 2032
Forecast Period 2023 - 2032 CAGR:
7.9
2023 Value Projection:
USD 3.2 Billion
Historical Data for:
2018 - 2023
No of Pages:
130
Tables, Charts & Figures:
219
Segments Covered:
Product, Application, End Use, and Region
Growth Drivers:
Growing demand for regenerative medicine
Rising incidence of chronic wounds
Advancements in biotechnology and tissue engineering
Increasing awareness and acceptance of amniotic membrane products
Pitfalls Challenges:
Limited shelf life of amniotic membrane products
Stringent regulatory polices
What are the growth opportunities in this market?
Additionally, the rising incidence of chronic wounds, advancements in biotechnology and tissue engineering, and increasing awareness and acceptance of amniotic membrane products also support revenue growth in the market. Educational initiatives, including medical conferences and training programs, are promoting an understanding among clinicians. Simultaneously, patient awareness and demand for advanced therapies have increased with greater access to medical information and advocacy efforts.
Amniotic Membrane Market Trends
The market is experiencing significant growth, driven by its wide-ranging applications in healthcare, especially in wound care, ophthalmology, and regenerative medicine.
The adoption of amniotic membrane transplantation to address ocular surface disorders, including corneal ulcers, chemical burns, and conjunctival defects, is increasing in ophthalmic surgeries. The rising popularity of cryopreserved amniotic membranes for corneal repair and regeneration stems from their efficacy in promoting healing and minimizing scarring in corneal epithelial defects and other surface disorders.
There's growing demand for amniotic membrane products in treating chronic wounds such as diabetic foot ulcers and pressure ulcers and venous leg ulcers. Additionally, due to their healing-promoting properties and pain-reducing effects, amniotic membranes are increasingly used in burn care.
Recent advancements in cryopreservation techniques have not only enhanced the efficacy and shelf-life of amniotic membrane products but also ensured the retention of their biological properties, amplifying their medical effectiveness.
The introduction of dehydrated amniotic membrane products has further invigorated the market, given their extended shelf life, ease of storage and transport, and comparable therapeutic benefits to their cryopreserved counterparts.
Amniotic Membrane Market Analysis
Learn more about the key segments shaping this market
Based on product, the market is divided into cryopreserved and lyophilized. The cryopreserved segment of the market is forecasted to reach USD 1.7 billion by 2032.
Cryopreserved amniotic membrane (CAM) is extensively utilized across various medical disciplines due to its unique properties. In ophthalmology, it is employed to treat corneal defects, such as persistent epithelial defects, ulcers, and chemical burns, thereby promoting faster healing and reducing inflammation and scarring.
In wound care, CAM has become an effective product for managing chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure sores. It provides a biological scaffold that supports cell proliferation and tissue regeneration. Additionally, its anti-inflammatory and antimicrobial properties help reduce infection risks and create a conducive healing environment, supporting its preference and revenue growth in the market.
Learn more about the key segments shaping this market
Based on application, the amniotic membrane market is bifurcated into surgical wounds, ophthalmology, stem cell biology, regenerative medicine, prenatal diagnosis, orthopedics, dermatology, plastic surgery, dentistry, and gynecology. The ophthalmology segment dominated the market with a revenue of USD 342.1 million in 2023.
Amniotic membrane transplantation (AMT) is utilized in ophthalmology to address various ocular surface disorders. The amniotic membrane, the innermost layer of the placenta, offers several beneficial properties, including providing a substrate for epithelial cell growth due to its collagen composition, reducing inflammation, preventing new blood vessel formation, and offering analgesic effects by covering nerve endings.
The growing prevalence of ocular surface disorders, including corneal ulcers, pterygium, and dry eye diseases, driven by factors such as aging populations and increased incidence of ocular trauma, is fueling demand for advanced treatment options. Additionally, advancements in surgical techniques and a better understanding of the benefits of amniotic membranes are expanding its applications and increasing its adoption.
Furthermore, enhanced availability and improved processing methods contribute to its growing use in ophthalmic procedures, making the membrane more accessible and easier to apply.
Based on end-use, the amniotic membrane market is bifurcated into hospitals, ambulatory surgical centers (ASCs), specialty clinics, research and academic institutes, and other end-users. The hospitals segment held a market share of 40.7% in 2023 and is estimated to grow significantly.
Hospitals benefit from the regenerative properties, anti-inflammatory effects, and scar-reducing capabilities of amniotic membranes, making them particularly valuable for treating chronic wounds, corneal defects, and during reconstructive surgeries.
They are especially effective in treating chronic wounds, burns, and post-surgical sites due to their anti-inflammatory, antifibrotic, and antimicrobial properties, which promote faster healing and reduce the risk of infection.
Increasing demand in hospital settings is driven by the need for advanced and effective treatment options to enhance patient outcomes, underscoring the significant role of amniotic membranes in contemporary medical care.
Looking for region specific data?
The growth of the amniotic membrane market in the U.S. is projected to reach USD 1.1 billion by 2032.
Key factors driving this growth include the presence of well-established healthcare facilities and leading industry players in the country. The increasing emphasis on regenerative medicine and the rapid adoption of advanced technologies also contribute to market expansion.
Additionally, the rising incidence of accidents, including road traffic collisions and trauma events, is anticipated to drive market growth. For example, as of March 2023, approximately 7.3 million motor vehicle accidents occur annually in the U.S.
Furthermore, favorable regulatory frameworks and ongoing investment in research and development are expected to support a positive market outlook during the forecast period.
The amniotic membrane market in the UK is expected to experience significant and promising growth from 2024 to 2032.
The country’s well-established public healthcare system and the widespread implementation of universal healthcare contribute to the growing demand for advanced medical treatments, including amniotic membranes.
Additionally, the rising prevalence of chronic diseases such as cardiovascular conditions, cancer, and diabetes is driving the need for effective regenerative therapies that support wound healing and tissue repair in the UK, further boosting market growth.
The amniotic membrane market in Japan is anticipated to witness lucrative growth between 2024 and 2032.
The availability of trained professionals and the development of healthcare facilities are expected to drive market growth in Japan during the forecast period. Rising awareness of the benefits provided by amniotic membranes is also expected to further propel market expansion.
Moreover, Japan's growing healthcare expenditure, which accounted for 9.8% of its GDP in 2022 according to the Organization for Economic Cooperation and Development (OECD), is projected to stimulate revenue growth in the market during the forecast period.
The amniotic membrane market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
This market growth is driven by several key factors, including high spending capacity and living standards, well-established medical infrastructure, and a rising incidence of cancer.
Additionally, increasing government initiatives aimed at expanding reimbursement coverage are expected to enhance market penetration during the forecast period. The projected rise in healthcare spending in Saudi Arabia, estimated at USD 50.4 billion for 2023, according to a report by the International Trade Administration and the U.S. Department of Commerce, is expected to further support market expansion.
Amniotic Membrane Market Share
The market is competitive, with a mix of major global and smaller to medium-sized companies vying for market share. Prominent players in the market include MiMedx Group, Inc., Smith & Nephew plc, Integra LifeSciences Holdings Corporation, and Organogenesis Holdings Inc. These leading companies employ various strategies to maintain competitive advantages, including strategic collaborations, partnerships, and mergers, allowing them to capture the highest market share and outperform the competition.
Amniotic Membrane Market Companies
Some of the eminent market participants operating in the amniotic membrane industry include:
Amnio Technology, LLC
Applied Biologics LLC
BioTissue Holdings Inc.
Celularity Inc.
Corza Health, Inc.
Integra LifeSciences Holdings Corporation
MiMedx Group, Inc.
Organogenesis Holdings Inc.
Skye Biologics, Inc.
Smith & Nephew plc
Amniotic Membrane Industry News:
In September 2023, MiMedx Group, Inc. announced the launch of EPIEFFECT, the latest addition to its portfolio of advanced wound care (AWC) solutions. The product features a thick, tri-layer configuration, making it suitable for securing the graft in place with sutures. Its product attributes and handling characteristics make it a preferable treatment option for deep or tunneling wounds.
In January 2023, MiMedx Group, Inc., a pioneer and leader in placental biologics, announced that it had entered into an exclusive distribution agreement with Gunze Medical Limited, a subsidiary of Gunze Limited, for the sale of EPIFIX in Japan. MiMedx received regulatory approval for EPIFIX from the Japanese Ministry of Health, Labour and Welfare in June 2021, with reimbursement approval at a rate of JPY 35,100/cm² in September 2022. This partnership provided MiMedx with a strategic advantage, expanding its market presence in Japan and increasing access to its innovative wound care solutions in the region.
The amniotic membrane market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:
to Buy Section of this Report
Market, By Product
Cryopreserved
Lyophilized
Market, By Application
Surgical wounds
Ophthalmology
Stem cell biology
Regenerative medicine
Prenatal diagnosis
Orthopedics
Dermatology
Plastic surgery
Dentistry
Gynecology
Market, By End Use
Hospitals
Ambulatory surgical centers (ASCs)
Specialty clinics
Research and academic institutes
Other end-users
The above information is provided for the following regions and countries:
North America
U.S.
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Middle East and Africa
South Africa
Saudi Arabia
UAE
Rest of Middle East and Africa
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
How big is the amniotic membrane market?+
The industry was valued at approximately USD 1.7 billion in 2023 and is estimated to grow at a 7.9% CAGR from 2024 to 2032, driven by its regenerative properties and applications in medical treatments and surgeries.
Why is the use of cryopreserved amniotic membrane rising?+
The cryopreserved segment is forecasted to reach USD 1.7 billion by 2032 due to its extensive use in various medical disciplines, such as ophthalmology, where it treats corneal defects, promotes faster healing, and reduces inflammation and scarring.
What is the size of the U.S. amniotic membrane market?+
The U.S. market is projected to reach USD 1.1 billion by 2032, driven by well-established healthcare facilities, leading industry players, a focus on regenerative medicine, and the rapid adoption of advanced technologies.
Who are the key players in the amniotic membrane industry?+